Chapter 17 AIDS and secondary immunodeficiency

49
Chapter 17 AIDS and secondary immunodeficiency Trai-Ming Yeh, Ph.D. Department of Medical Laboratory Science and Biotechnology College of Medicine National Cheng Kung University

description

Chapter 17 AIDS and secondary immunodeficiency. Trai-Ming Yeh, Ph.D. Department of Medical Laboratory Science and Biotechnology College of Medicine National Cheng Kung University. Secondary (acquired) immunodeficiency. Primary vs. acquired immunodeficiency Acquired immunodeficiency - PowerPoint PPT Presentation

Transcript of Chapter 17 AIDS and secondary immunodeficiency

Page 1: Chapter 17  AIDS and secondary immunodeficiency

Chapter 17 AIDS and secondary immunodeficiency

Trai-Ming Yeh, Ph.D.

Department of Medical Laboratory Science and Biotechnology

College of Medicine

National Cheng Kung University

Page 2: Chapter 17  AIDS and secondary immunodeficiency

Secondary (acquired) immunodeficiency

• Primary vs. acquired immunodeficiency• Acquired immunodeficiency

– Immunosuppressive drugs immune enhancement• Corticosteroids

• Cytotoxic immunosuppressants

• Fungal and bacterial derivatives

• Monoclonal antibodies

– Malnutrition-induced immunodeficiency

– Infection-induced immunodeficiency• HIV

Page 3: Chapter 17  AIDS and secondary immunodeficiency

Anti-inflammatory drugs• 例子

– Prednisone modified from cortisol

• 應用– Transplantation

– Autoimmune disease

– Allergic disease

• 副作用– Fluid retention, weight gain,

diabetes, bone mineral loss, thinning of the skin

和 cytotoxic drug 一起使用

Page 4: Chapter 17  AIDS and secondary immunodeficiency

Corticosteroids bind to their intracellular receptors and regulate gene

expression

Page 5: Chapter 17  AIDS and secondary immunodeficiency

Genes affected by steroid

• Function– 減少 inflammatory

mediator的製造

– 使 adhesion molecules表現下降

– Endonuclease製造上升

Page 6: Chapter 17  AIDS and secondary immunodeficiency

1. Neutrophilia, lymphocytopenia, monocytopenia2. T cell activation and B cell maturation are inhibited3. Cytokine synthesis is inhibited

Page 7: Chapter 17  AIDS and secondary immunodeficiency

Cytotoxic immunosuppressants

和 IMP競爭 DNA合成所需酵素

DNA covalent alkylation

Azathioprine(cytostatic)

Mycophenolate(inhibits de-novo purine biosynthesis)

Cyclophosphamide(cytotoxic)

Page 8: Chapter 17  AIDS and secondary immunodeficiency

Cytotoxic drugs• Methotrexate blocks DNA synthesis• leflunomide is converted to A77 1726 which inhibits

dihydro-orotate dehydrogenase, an enzyme required for pyrimidine nucleotide synthesis

• 副作用– Leukopenia, thrombocytopenia, intestinal epithelium injury, hair

loss, fetal death

• 應用– Eliminate unwanted immune responses– Eliminate all dividing lymphocyte : high dose

Page 9: Chapter 17  AIDS and secondary immunodeficiency

Fungal and bacterial derivatives• 機制

– 干擾 T cell的訊息傳遞– 和 immunophilins(一種胞內蛋白)結合,干擾

對 T cell增生重要之訊息途徑• 例子

– Ciclosporin (Cyclosporin A) : Tolypocladium inflatum

– FK506 (tacrolimus) : Streptomyces tsukabaensis– Rapamycin : Streptomyces hygroscopicus

Page 10: Chapter 17  AIDS and secondary immunodeficiency

Cyclosporin A & FK506

• 應用:– Prevent allogenic graft rejection:能抑制對特定抗原產生反應的 T cell之增生

– 手術時:高劑量– 手術後:劑量降低

• 缺點– 對其它器官的傷害( eg. kidney 和 T cell有相同的 target)

Page 11: Chapter 17  AIDS and secondary immunodeficiency

Cyclosporin A & FK506

Page 12: Chapter 17  AIDS and secondary immunodeficiency

Cyclosporin A FK506 (tacrolimus)

• 機制– 使 calcineurin 的

phosphotase活性受抑制,進而使 T cell增生受抑制

– Cyclosporin A + cyclophilins

– FK506 + FKBP

Page 13: Chapter 17  AIDS and secondary immunodeficiency
Page 14: Chapter 17  AIDS and secondary immunodeficiency

Rapamycin

• 機制: rapamycin-immunophilin block signal transduction pathway of IL-2 receptor but not T cell activation, cause G1 arrest

mTOR

磷酸化 p70S6 kinase

PHAS-1( repressor)磷酸

調控蛋白質之轉譯

活性下降Rapamycin-immunophilin

磷酸化(抑制活性)

Page 15: Chapter 17  AIDS and secondary immunodeficiency
Page 16: Chapter 17  AIDS and secondary immunodeficiency
Page 17: Chapter 17  AIDS and secondary immunodeficiency

NUTRIENT DEFICIENCIES ARE GENERALLY ASSOCIATED WITH IMPAIRED IMMUNE

RESPONSES• Infection and malnutrition usually aggravate each other • Lymphoid tissues are damaged by nutrient deficiencies• Protein-energy malnutrition affects cell-mediated immunity and

phagocytosis• Zinc and iron deficiencies have a variety of effects on immunity• Selenium and copper are also important for immune responses• Vitamin supplementation is of value in severe measles

– Vitamin A deficiency– Vitamin B6 and folate deficiencies

• Obesity is associated with altered immune responses• Some nutrients in moderate excess enhance immune responses

– vitamin E; vitamin A; zinc; and selenium

• Probiotics benefit health and immunity

Page 18: Chapter 17  AIDS and secondary immunodeficiency

ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)

• The most significant global cause of immunodeficiency is HIV infection

• CD4 antigen is the main receptor for HIV entry: The viral envelope glycoprotein gp120 binds to CD4

• Immune dysfunction results from the direct effects of HIV and impairment of CD4 T cells

• Antibody response appears to be ineffective in controlling HIV infection

• Cellular immune responses play a role in controlling HIV viremia– HIV-1-specific CTLs in chronic progressive HIV-1 infection are

impaired– HIV-1-specific CD4 T cells are preferentially infected by the virus

Page 19: Chapter 17  AIDS and secondary immunodeficiency
Page 20: Chapter 17  AIDS and secondary immunodeficiency

Acute HIV infection is associated with a transient depletion of peripheral CD4 T cells

AIDS is defined by a CD4 count < 200/μl

Page 21: Chapter 17  AIDS and secondary immunodeficiency

Seroconversion: Antibody against HIV positive

Page 22: Chapter 17  AIDS and secondary immunodeficiency

• The most significant global cause of immunodeficiency is HIV infection

• CD4 antigen is the main receptor for HIV entry: The viral envelope glycoprotein gp120 binds to CD4

• Immune dysfunction results from the direct effects of HIV and impairment of CD4 T cells

• Antibody response appears to be ineffective in controlling HIV infection

• Cellular immune responses play a role in controlling HIV viremia– HIV-1-specific CTLs in chronic progressive HIV-1 infection are

impaired– HIV-1-specific CD4 T cells are preferentially infected by the virus

Page 23: Chapter 17  AIDS and secondary immunodeficiency

More severe infections are associated with a low CD4 count

1. Kaposi's sarcoma: Infection with human herpes virus 8 (HHV8)

2. Pneumonia is common and Pneumocystis carinii is the commonest infection (see Fig. 17.6), but bacterial infections, including Mycobacterium tuberculosis, and fungal infections also occur.

3. candidiasis (thrush), diarrhea and weight loss (see Fig. 17.6)

4. Toxoplasmosis, a protozoal infection, causes cysts in the brain and neurological deficit (see Fig. 17.6).

5. Cryptococcus neoformans is a fungus that causes meningitis.

Page 24: Chapter 17  AIDS and secondary immunodeficiency

Treatment with highly active antiretroviral therapy (HAART) controls HIV infection

1. zidovudine (AZT) was licensed as the first nucleoside analog reverse transcriptase inhibitor (NRTI)

2. non-nucleoside reverse transcriptase inhibitors (NNRTIs)

3. protease inhibitors4. entry inhibitors 5. Combination chemotherapy (HAART):

two NRTIs; and a NNRTI or protease inhibitor.

Page 25: Chapter 17  AIDS and secondary immunodeficiency

HIV vaccine

• An effective vaccine remains an elusive goal

Page 26: Chapter 17  AIDS and secondary immunodeficiency

99.12.2, 中國時報 疾病管制局 2010 年 10 月底統計資料顯示,累積本國籍通報為愛滋病毒感染者計 1 萬 9735 例,依感染危險因素分析,性行為佔 65.5% (未具防護的男性間性行為佔 43.4% 、異性間性行為佔 22.1% )。其次為共用針具與稀釋液佔32.6% ,顯見行為才是主因。感染者年齡則以 20 至 29 歲最多,佔 38.1% ,其次為 30 至 39 歲,佔 35.2 % 。特別要注意的是,年輕族群( 15- 24 歲)感染愛滋近年來有逐漸增加的趨勢。年輕族群在 2007 年佔總通報人數的 14% ( 272例)、 2008 年佔 20% ( 351 例),到 2009 年更上升至 28% ( 413 例)。值得重視的是,年輕族群 90% 都是性行為傳染。因此不論是男性或女性、同性戀或異性戀,以及職業類別,只如果從事不戴保險套防護的性行為、與性交往史不明對象間的性行為,以及共用針具與稀釋液等,都可以感染上愛滋病毒。 12月 1 日是世界愛滋日,根據世界衛生組織建議,使用保險套可以有效阻隔體液(精液、陰道分泌物或血液)進入人體,將感染愛滋與性病的機率降到最低。只要全程正確使用保險套,不沾染毒品,就能杜絕愛滋感染。愛滋病空窗期約是愛滋病毒感染後 6-12 週內,民眾勿以捐血方式來篩檢愛滋病毒,除危及用血者的安全外,亦可能因此觸法,若有需要可至愛滋病指定醫院進行篩檢,懷疑自己可能感染愛滋病毒,但又擔心檢驗後身份曝光而不敢接受檢驗的民眾,則可至衛生署疾病管制局委託愛滋病指定醫院設立之免費匿名的篩檢諮詢管道進行篩檢,政府有一個全民「認識愛滋、支持篩檢、及早治療」,請說明愛滋篩檢的免疫原理。

Page 27: Chapter 17  AIDS and secondary immunodeficiency

Chapter 18 Vaccination

Trai-Ming Yeh, Ph.D.

Department of Medical Laboratory Science and Biotechnology

College of Medicine

National Cheng Kung University

Page 28: Chapter 17  AIDS and secondary immunodeficiency

Summary of Chapter 18 Vaccination • Vaccination applies immunological principles to human

health. • A wide range of antigen preparations are in use as

vaccines.• Adjuvants enhance antibody production.• Most vaccines are still given by injection.• Vaccine efficacy needs to be reviewed from time to time. • Vaccine safety is an overriding consideration. • Vaccines in general use have variable success rates. • Passive immunization can be life-saving. • Non-specific immunotherapy can boost immune activity. • Immunization against a variety of non-infectious conditions

is being investigated.

Page 29: Chapter 17  AIDS and secondary immunodeficiency

Vaccines have two major effects- Individuals and herd immunity

Page 30: Chapter 17  AIDS and secondary immunodeficiency

A WIDE RANGE OF ANTIGEN PREPARATIONS ARE IN USE AS VACCINES

Page 31: Chapter 17  AIDS and secondary immunodeficiency

Live vaccines can be natural (rare) or attenuated organisms

Page 32: Chapter 17  AIDS and secondary immunodeficiency

Attenuated live vaccines have been highly successful

1. ATTENUATED MICROORGANISMS ARE LESS ABLE TO CAUSE DISEASE IN THEIR NATURAL HOST

2. VACCINIA VIRUS IS BEING USED AS A VECTOR FOR ANTIGENS OF MICROORGANISMS SUCH AS HIV AND MALARIA

Page 33: Chapter 17  AIDS and secondary immunodeficiency

Killed vaccines are intact but non-living organisms

Page 34: Chapter 17  AIDS and secondary immunodeficiency

Inactivated toxins and toxoids are the most successful bacterial vaccines

Page 35: Chapter 17  AIDS and secondary immunodeficiency

Subunit vaccines and carriers

Page 36: Chapter 17  AIDS and secondary immunodeficiency

Adjuvants enhance antibody produciton by concentrate antigen at appropriate sites or induce cytokines

Page 37: Chapter 17  AIDS and secondary immunodeficiency

Anti-idiotype vaccines could be used when the original antigen was unsuitable

Page 38: Chapter 17  AIDS and secondary immunodeficiency

Induction of appropriate immunity depends on the properties of the antigen

Page 39: Chapter 17  AIDS and secondary immunodeficiency

VACCINE SAFETY IS AN OVERRIDING CONSIDERATION

Page 40: Chapter 17  AIDS and secondary immunodeficiency

VACCINES IN GENERAL USE HAVE VARIABLE SUCCESS RATES

Page 41: Chapter 17  AIDS and secondary immunodeficiency
Page 42: Chapter 17  AIDS and secondary immunodeficiency
Page 43: Chapter 17  AIDS and secondary immunodeficiency

Vaccines for parasitic and some other infections are only experimental

Page 44: Chapter 17  AIDS and secondary immunodeficiency

PASSIVE IMMUNIZATION CAN BE LIFE-SAVING

Page 45: Chapter 17  AIDS and secondary immunodeficiency

NON-SPECIFIC IMMUNOTHERAPY CAN BOOST IMMUNE ACTIVITY

Page 46: Chapter 17  AIDS and secondary immunodeficiency

注射新 H1N1 疫苗後後的局部不良反應包括發紅、疼痛、腫脹、瘀血等,另有些人有全身性不良反應包括鼻塞、發燒、肌肉酸痛、頭痛、噁心、嘔吐,如果對疫苗的成份如雞蛋的成份過敏,甚至會引發全身性的休克反應。國內注射新流感疫苗發生一般的輕微的不良反應的比率與國外相似。但 2010 年 H1N1流行時有一位七歲男童接種國光的新流趕疫苗後,隔天出現紅疹、發燒等症狀,先後住院治療,但仍在注射新流感疫苗後 40天後死於敗血症,這位男童有『全身性幼年性類風濕關節炎』的病史,因此事件引起對新流感疫苗是否安全的疑慮,也造成國人接種意願的降低,請您免疫學的觀點評論此事。

Page 47: Chapter 17  AIDS and secondary immunodeficiency

IMMUNIZATION AGAINST A VARIETY OF NON-INFECTIOUS CONDITIONS IS BEING

INVESTIGATED (tumor vaccine?)

• Future vaccines will use genes and vectors to deliver antigens– Vaccinia is a convenient vector

– BCG and salmonellae have been favored for experimental recombinant bacterial vaccines

– Transgenic plants can be genetically engineered to express vaccine antigens

– A recent development is the use of ‘naked’ DNA (gene gun) (without needle injection)

Page 48: Chapter 17  AIDS and secondary immunodeficiency

bUDR: bromodeoxyuridineThymidine analogTK: thymidine kinase

Page 49: Chapter 17  AIDS and secondary immunodeficiency

Important points needed to understand after class

• How does HIV infection cause AIDS?• The role of vaccine in preventive medicine.• The development and use of vaccine.